
Understand what the student will learn in section 1.0 Introduction
What are the learning objective.
You will understand the transition from the medical device directives to the medical device regulation.
What will the changes bring.
What does the medical device regulation contain.
I will give a quick summary of the chapters and the annexes. I want students to understand that this is a brief summary of the Medical device regulation. The module will explain the principles of the regulation in further detail
•Understand the challenges associated with the transition to the In vitro diagnostics regulation 2017/746
Understand in simple terms what an In Vitro diagnostic medical device is.
Understand a case study to examine why medical device marketing European Legislation changed.
Understand what the student will learn in section 2.0 Economic Operators.
•Who are the economic operators?
•Obligation of economic operator.
•Responsibilities within the supply chain.
•Understand the definition of the authorised representative.
•Understand the obligations of the authorised representative.
•Understand the definition of the distributor.
•Understand the obligations of the distributor.
•We will understand the role and responsibilities of the Importer.
•We will understand the definition of the importer.
•We will understand who audits the importer.
We will understand the definition of the manufacturer.
We will Understand the obligations of the manufacturer.
•We will understand when an economic operator obligation will change to that of a manufacturer.
•Understand the obligations of the Person Responsible for Regulation Compliance (PRRC)
•Understand the qualifications required to become a PRRC.
•Understand the responsibilities of the PRRC.
•Understand who is expected to have a PRRC.
•Understand when a PRRC can be hired in a consultant role.
•Understand that a PRRC can carry out their work without been disadvantaged.
Understand what the student will cover in section 3.0 EUDAMED
•Understand who the Actors are.
•Understand the single registration number.
•An example of a registration.
•The validation process of an actor.
We will understand the timelines associated with the implementation of EUDAMED.
Understand what is covered in this section
What will we learn?
We will understand where the UDI is primarily mentioned within the regulation.
We will understand what is the Unique Device Identification Database.
We will learn what a Basic Unique Device Identifier is.
What will we learn?
How is the Unique Device Identification created.
Understand the Unique Device Identification-Carrier. What is the system used to create the code.
Understand the AIDC “Automatic identification and data capture”. The machine readable part of the identification code.
Understand the HRI “Human Readable Interpretation “. The readable part of the code.
Understand the Unique Device Identification-Device Identifier. Which is called the UDI-DI.
Understand the Unique Device Identification-Production Identifier. Which is called UDI-PI.
Companies accredited with creating Unique device identification carriers. Which companies have been approved by the EU commission to create the Carrier ID.
•Understand who the current accredited organisations are that can create Unique device identification carrier standards.
•An introduction to their standards.
•Their role and responsibility within the regulation.
Understand when the UDI needs to be inputted into the EUDAMED data base.
Understand the timelines for labelling in vitro diagnostic medical devices with the UDI.
We will understand what is covered in section 5.0
•Understand in simple terms what an In Vitro diagnostic medical device is.
•Look at some examples.
•Understand the principle of qualification, classification and conformity assessment.
Understand what is meant by classification.
We will understand some examples to illustrate the classification.
We will understand the definitions that will help us to classify an in vitro diagnostic medical devices into their classification's levels.
What will we learn?
We will understand what is meant by the intended purpose of an in vitro diagnostic medical device.
We will understand what is meant by the Implementing rules within the context of the regulation.
We will briefly look at the 7 rules which helps the manufacturer classify their in vitro diagnostic medical device.
What will we learn?
We will take an example of an in vitro diagnostic medical device and go through the rules to classify this device. Our example in this case will be a syphilis test.
What will we learn?
We will take an example of an in vitro diagnostic medical device and go through the rules to classify this device. Our example in this case will be a Non-typhoidal anti-salmonella antibodies.
We will understand the 7 rules for classification of an invitro diagnostic medical device.
We are going to go through all the rules in this lecture, so the time of the lecturer will be a little longer that usual, but hang in there, it will be beneficial
What will we learn?
We will understand how to classify a SARs-CoV-2 Rapid antigen test.
What will we learn?
We learn where software qualification and classification fits into the puzzle.
We will discuss what is covered in section 6.0
What will we learn?
What is the conformity assessment route for a class A in vitro diagnostic medical device.
What is the conformity assessment route for a class A sterile in vitro diagnostic medical device.
What will we learn?
What is the conformity assessment route for a class B in vitro diagnostic medical device.
What is the conformity assessment route for a class B in vitro diagnostic medical device for near patient testing NPT and self testing.
What will we learn?
What is the conformity assessment route for a class C in vitro diagnostic medical device. In this context we are excluding devices that are used for near patient testing NPT and self testing.
What is the conformity assessment route for a class C in vitro diagnostic medical device for near patient testing NPT and self testing.
What is the Conformity assessment route for a class C device which is a companion diagnostic (CDx)
What will we learn?
What is a Common specification.
What is EU Reference Laboratories.
What is the conformity assessment route for a Class D in vitro diagnostic medical device (excluding CDx), with Common Specification.
What is the conformity assessment route for a class D in vitro diagnostic medical device(excluding CDx), with no Common Specification.
What is the conformity assessment route for a class D in vitro diagnostic medical device Companion Diagnostic.
Explain what is contained within section 7.0
What will we learn?
Understand Annex I which is the general safety and performance requirements that the regulation mandates of a medical device.
Understand chapter 1 – General requirements.
Understand Chapter 2 – Performance, Design and manufacturing.
Understand Chapter 3 – Labels and Instruction for Use.
Understand how standards support the GSPR.
What will we learn?
What the intended purpose is and how this is broken up into certain sections
The Intended patient population.
The medical indication.
The user.
How to use the device.
How to create the claims.
Risk vs Benefit.
What will we learn?
What clinical evaluation is.
When clinical evaluation is undertaken.
Why is clinical evaluation important.
What is performance evaluation
What Equivalence is.
What will we learn?
Why the manufacturer needs a post market performance follow up.
Post Market Clinical Follow up plan.
Method of collecting data.
We will understand what we will learn in Section 8 of Post Market Surveillance
What will we learn?
•What does the regulation call out for regarding Post Market Surveillance.
•What a post market surveillance system should comprise of.
•How will the data be utilized that is gathered from the post market surveillance system.
•What will a manufacturer do with that data.
•What is a PMS plan.
What will we learn.
We will understand what a post market surveillance report is. We will understand what a Periodic safety update report is
We will understand what is meant by reporting of serious incidents and field safety corrective actions.
We need to understand that we are now in the realm of being reactive. What does this mean. The manufacturer is reaction to signals of the device in the market place.
What will we learn?
We will understand what is meant by Analysis of serious incidents and field safety corrective actions.
This is covered under article 84 which is contained in Chapter VII under vigilance section 2.
We will also examine article 85 which is the analysis of vigilance data.
What will we learn?
•Market surveillance
•Role and responsibility of the competent authority
•Role and responsibility of the commission.
We will explain what is in section 9.0 Miscellaneous
What will we learn?
What is the impact of the UK leaving the EU. (Brexit)
What will we learn.
We will understand what is meant by the medical device coordination group.
What will we learn?
Understand common specification within the context of the IVDR
What will we learn.
Understand the Mutual Recognition Agreement between Switzerland and the EU,
What is the current status of the MRA.
How does this affect the IVDR 2017/746 in Switzerland.
What will we learn.
Understand the association agreement with Turkey and the EU.
Understand the bilateral agreements with the EFTA.
How does this affect the IVDR 2017/746 Turkey and the EFTA.
What will we learn?
We will understand what the rolling plan is.
The Rolling Plan. The European commissions road map for the implementation of the IVDR 2017 746.
What will we learn.
We will understand what the European Union Reference Laboratories are.
We will understand what the National Reference Laboratories are.
We will understand how the EURL network supports the IVDR.
We will understand the tasks of the EURL.
In this section material will be added to reference for example guidance documents
This Course is broken into nine sections. The objective of the course is to explain the in vitro diagnostic medical device regulation 2017/746 in simple terms:
Section 1 Introduction.
Introduction to the in vitro diagnostic medical device regulation 2017 746.
Why was there a change from the directive to the IVDR 2017 746?
The timelines for the transition of the IVDR 2017 746.
Section 2 Economic Operator.
Economic Operators. Who are they?
Economic Operator. The European Authorised representative. Explain their obligation.
Economic Operator. The Distributor. Explain their obligation.
Economic Operator. The Importer. Explain their obligation.
Economic Operator. The Manufacturer. Explain their obligation.
When does an Economic operator obligation change?
Explain the obligation of a person responsible for regulatory compliance
Section 3 EUDAMED
Introduction to what EUDAMED is.
Understand what is meant by the actor registration.
The timelines for the transition of EUDAMED system
Section 4 Unique Device Identification and registration
UDI Introduction. What is it? Why is it needed?
UDI The Carrier. Understand the unique device identification carrier.
UDI Accredited Organisation. Understand who the current accredited organisations are that can create Unique Device identification carrier standards.
UDI timelines. When the UDI carrier needs to be attached to the packaging and devices.
Section 5 Classification of in vitro diagnostic medical devices
Qualification of in vitro diagnostic medical devices. Determine if the manufacturer is making a medical device.
Classification of in vitro diagnostic medical devices Introduction.
Understand in vitro diagnostic medical device definitions. This will help the student how to classify a medical device.
Rules of in vitro diagnostic medical device classification. Understand the implementation of the rules.
IVDR apply in vitro diagnostic medical device rules.
Section 6 Conformity assessment
Explain the Conformity assessment path for Class A in vitro diagnostic medical devices. Explain the Conformity assessment path for Class B in vitro diagnostic medical devices. Explain the Conformity assessment path for Class C in vitro diagnostic medical devices. Explain the Conformity assessment path for Class D in vitro diagnostic medical devices.
Section 7 Sufficient Clinical data
The General Safety and Performance Requirements.
The Intended purpose.
Sufficient clinical Data. Clinical Evaluation.
Post Market Performance Follow up (PMPF).
Section 8 Post Market Surveillance.
Post Market Surveillance.
Post-market surveillance report & Periodic safety update.
Post-market vigilance.
Analysis of vigilance data.
Role of Competent Authority & European Commission within Market Surveillance
Section 9 Other Items
Medical device coordination group
Brexit
Switzerland Mutual Recognition Agreement
Turkey and EFTA agreement with the EU.
Common Specifications
The Rolling plan.
European Union Reference Laboratories
The benefits of the course will be:
Save you time.
Really understand regulation in simple terms.
Help you prioritizes work to prepare for the IVDR 2017 746 timelines.
Understand why regulation was introduced.
Know your obligation to the IVDR 2017 746.
Know the obligation to EUDAMED and the timelines.
Examples of how Unique Device Identification carriers are created.
Worked examples how in vitro diagnostic medical devices are classified.
Know the conformity assessment route to take for each in vitro diagnostic medical device.
Know what sufficient clinical data to collect to be compliant.
Understand the market surveillance requirements to allow the in vitro diagnostic medical device to stay in the marketplace.
Understand the UK and EU manufacturers responsibility post Brexit.
Understand Turkey and the EFTA (Switzerland, Liechtenstein, Norway, and Iceland) manufacturers responsibility regarding the IVDR 2017 746.
Understand how the European Union Reference laboratories support the implementation of the IVDR.